找化学品上960化工网!
960化工网

丁螺环酮 | 36505-84-7

丁螺环酮结构式图片|36505-84-7结构式图片
丁螺环酮
Buspirone
36505-84-7
C21H31N5O2
385.50314
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:丁螺环酮结构式
2477
丁螺环酮价格
简介
Buspirone 是一种口服有效的 5-HT1A 受体激动剂 (5-HT1A receptor)。Buspirone 是一种有效的抗癌剂。Buspirone 显示出抗增殖活性。Buspirone 可用于焦虑和抑郁研究。
名称和标识符
MDL MFCD00243004
InChIKey QWCRAEMEVRGPNT-UHFFFAOYSA-N
Inchi 1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2
SMILES O=C(N(CCCCN1CCN(C2=NC=CC=N2)CC1)C(C3)=O)CC43CCCC4
别名信息
- 中文别名 -
  • 丁螺环酮
  • 8-[4-(嘧啶-2-基)-1-哌嗪基丁基]-8-氮杂螺[4,5]癸烷-7,9-二酮
  • 丁螺环酮系统适用性 EP标准品
  • 丁螺环酮杂质
  • 8-[4-[4-(2-嘧啶基)-1-哌嗪基]丁基]-8-氮杂螺[4.5]癸烷-7,9-二酮
  • 螺氮癸嘧哌嗪
- 英文别名 -
  • 8-(4-(4-(Pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione
  • 8-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4,5]decane-7,9-dione
  • Buspar
  • Buspirone
  • 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione
  • 8-[4-[4-(pyrimidine-2-yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7,9-dione
  • ACETAMINOTADALAFIL
  • [14C]-Buspirone
  • 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro(4.5)-decane-7,9-dione
  • Ansial
  • Ansiced
  • Anxiron
  • Bespar
  • Buspirona
  • Buspirona [INN-Spanish]
  • Buspironum
  • Buspironum [INN-Latin]
  • ​HX-129
  • 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-
  • 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione
  • NCGC00024905-03
  • Buspirone free base
  • NCGC00015162-01
  • NCGC00015162-02
  • N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide
  • FT-0621488
  • SPBio_002418
  • Tox21_110092
  • buspirone
  • N05BE01
  • D07593
  • AB00053432-12
  • KBioSS_002236
  • 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione
  • Hydrochloride(Buspirone)
  • BRD-K93461745-001-01-5
  • 8-(4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl)-8-azaspiro[4.5]decane-7,9-dione #
  • TK65WKS8HL
  • SDCCGSBI-0050211.P004
  • Prestwick3_000369
  • BSPBio_000497
  • C06861
  • BCI-024
  • Spectrum_001756
  • SCHEMBL16398
  • NCGC00015162-03
  • NCGC00015162-03
  • Gen-Buspirone
  • Gen-Buspirone
  • Buspiron
  • Buspiron
  • 8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione
  • 8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione
  • 116753-41-4
  • 116753-41-4
  • 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4,5]decane-7,9-dione
  • 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4,5]decane-7,9-dione
  • Buspirone-MDTS
  • Buspirone-MDTS
  • Buspirone
  • 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]- (9CI)
  • Buspirone
  • 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]- (9CI)
  • Buspirona (INN-Spanish)
  • Buspirona (INN-Spanish)
  • BRD-K93461745-003-14-4
  • BRD-K93461745-003-14-4
  • BRD-K93461745-003-14-4
  • NCGC00015162-11
  • NCGC00015162-11
  • NCGC00015162-11
  • AB00053432
  • AB00053432
  • AB00053432
  • DTXSID2022707
  • DTXSID2022707
  • DTXSID2022707
  • 8-(4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl)-8-azaspiro(4.5)decane-7,9-dione
  • 8-(4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl)-8-azaspiro(4.5)decane-7,9-dione
  • 8-(4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl)-8-azaspiro(4.5)decane-7,9-dione
  • BPBio1_001403
  • BPBio1_001403
  • BPBio1_001403
  • MRF-0000691
  • Lopac-B-7148
  • MRF-0000691
  • MRF-0000691
  • Lopac-B-7148
  • Lopac-B-7148
  • AKOS002313325
  • AKOS002313325
  • DivK1c_000921
  • AKOS002313325
  • NCGC00015162-05
  • DivK1c_000921
  • DivK1c_000921
  • BPBio1_000547
  • NCGC00015162-05
  • NCGC00015162-05
  • BPBio1_000547
  • SBI-0050211.P003
  • BPBio1_000547
  • Tocris-0962
  • SBI-0050211.P003
  • SBI-0050211.P003
  • Tocris-0962
  • NCGC00016820-01
  • Tocris-0962
  • EN300-19748949
  • NCGC00016820-01
  • NCGC00016820-01
  • NCGC00024905-01
  • EN300-19748949
  • EN300-19748949
  • NCGC00024905-01
  • 8-Azaspiro[4.5]decane-7,9-dione,8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-
  • NCGC00024905-01
  • 8-Azaspiro[4.5]decane-7,9-dione,8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-
  • BRD-K93461745-003-03-7
  • 8-Azaspiro[4.5]decane-7,9-dione,8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-
  • BRD-K93461745-003-03-7
  • BRN 0964904
  • BRD-K93461745-003-03-7
  • BRN 0964904
  • Buspirone [INN:BAN]
  • BRN 0964904
  • NCGC00015162-07
  • Buspirone [INN:BAN]
  • Buspirone [INN:BAN]
  • Tox21_110092_1
  • NCGC00015162-07
  • NCGC00015162-07
  • 8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl)-
  • Tox21_110092_1
  • Tox21_110092_1
  • 8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl)-
  • 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione : (Hydrochloride)
  • 8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl)-
  • 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione : (Hydrochloride)
  • Prestwick1_000369
  • 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione : (Hydrochloride)
  • Buspirone (INN)
  • Prestwick1_000369
  • Prestwick1_000369
  • EX-A8006F
  • Buspirone (INN)
  • Buspirone (INN)
  • KBio2_002236
  • EX-A8006F
  • EX-A8006F
  • A924049
  • KBio2_002236
  • KBio2_002236
  • 8-{4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl}-8-azaspiro[4.5]decane-7,9-dione
  • A924049
  • A924049
  • 8-[4-[4-(pyrimidine-2yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7.9-dione
  • BUSPIRONE [MI]
  • 8-{4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl}-8-azaspiro[4.5]decane-7,9-dione
  • 8-{4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl}-8-azaspiro[4.5]decane-7,9-dione
  • 8-[4-[4-(pyrimidine-2yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7.9-dione
  • NCGC00015162-08
  • 8-[4-[4-(pyrimidine-2yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7.9-dione
  • NCGC00015162-06
  • BUSPIRONE [MI]
  • BUSPIRONE [MI]
  • NCGC00015162-08
  • NCGC00015162-08
  • DB00490
  • NCGC00015162-06
  • 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-
  • NCGC00015162-06
  • DB00490
  • NS00005411
  • DB00490
  • 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-
  • 36505-84-7
  • 8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-
  • NS00005411
  • BUSPIRONE [WHO-DD]
  • NS00005411
  • 36505-84-7
  • CCG-204318
  • 36505-84-7
  • BUSPIRONE [WHO-DD]
  • BUSPIRONE [WHO-DD]
  • KBio1_000921
  • CCG-204318
  • CCG-204318
  • KBio2_007372
  • KBio1_000921
  • Prestwick0_000369
  • KBio1_000921
  • KBio2_007372
  • NCGC00024905-02
  • KBio2_007372
  • Prestwick0_000369
  • Prestwick0_000369
  • 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]-butyl]-8-azaspiro[4.5]decane-7,9-dione
  • NCGC00024905-02
  • NCGC00024905-02
  • W-106606
  • 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]-butyl]-8-azaspiro[4.5]decane-7,9-dione
  • 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]-butyl]-8-azaspiro[4.5]decane-7,9-dione
  • NINDS_000921
  • W-106606
  • W-106606
  • NINDS_000921
  • CAS-36505-84-7
  • CAS-36505-84-7
  • NINDS_000921
  • Tox21_302371
  • CAS-36505-84-7
  • Tox21_302371
  • BUSPIRONEHYDROCHLORIDE
  • Tox21_302371
  • BUSPIRONEHYDROCHLORIDE
  • EINECS 253-072-2
  • BUSPIRONEHYDROCHLORIDE
  • EINECS 253-072-2
  • NCGC00255227-01
  • EINECS 253-072-2
  • NCGC00255227-01
  • Buspirone 100 microg/mL in Acetonitrile
  • NCGC00255227-01
  • Buspirone 100 microg/mL in Acetonitrile
  • 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4,5]decane-7,9-dione
  • Buspirone 100 microg/mL in Acetonitrile
  • 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4,5]decane-7,9-dione
  • Buspirone 1000 microg/mL in Acetonitrile
  • Buspirone 1000 microg/mL in Acetonitrile
  • 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4,5]decane-7,9-dione
  • UNII-TK65WKS8HL
  • UNII-TK65WKS8HL
  • Buspirone 1000 microg/mL in Acetonitrile
  • IDI1_000921
  • IDI1_000921
  • UNII-TK65WKS8HL
  • Q412194
  • IDI1_000921
  • Q412194
  • AB00053432_13
  • Q412194
  • DTXCID402707
  • AB00053432_13
  • BDBM50001859
  • AB00053432_13
  • DTXCID402707
  • DTXCID402707
  • L001110
  • BDBM50001859
  • BDBM50001859
  • BUSPIRONE [VANDF]
  • L001110
  • HMS2090K19
  • L001110
  • BUSPIRONE [VANDF]
  • BIDD:GT0519
  • BUSPIRONE [VANDF]
  • HMS2090K19
  • NCGC00015162-22
  • HMS2090K19
  • BIDD:GT0519
  • Buspironum (INN-Latin)
  • BIDD:GT0519
  • NCGC00015162-22
  • Gen-Buspirone (TN)
  • NCGC00015162-22
  • Buspironum (INN-Latin)
  • (buspirone) 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione
  • Buspironum (INN-Latin)
  • Gen-Buspirone (TN)
  • NCGC00015162-04
  • Gen-Buspirone (TN)
  • (buspirone) 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione
  • Prestwick2_000369
  • (buspirone) 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione
  • NCGC00015162-04
  • GTPL36
  • NCGC00015162-04
  • Prestwick2_000369
  • CAS-33386-08-2
  • Prestwick2_000369
  • Lopac0_000223
  • GTPL36
  • GTPL36
  • 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione
  • CAS-33386-08-2
  • CAS-33386-08-2
  • NCGC00015162-10
  • Lopac0_000223
  • 8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione
  • Lopac0_000223
  • 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione
  • NCGC00015162-10
  • KBio2_004804
  • 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione
  • 8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione
  • CHEBI:3223
  • NCGC00015162-10
  • CHEMBL49
  • 8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione
  • KBio2_004804
  • buspin
  • KBio2_004804
  • CHEBI:3223
  • BUSPIRONE [INN]
  • CHEBI:3223
  • CHEMBL49
  • buspin
  • CHEMBL49
  • Biomol-NT_000108
  • BUSPIRONE [INN]
  • buspin
  • Biomol-NT_000108
  • BUSPIRONE [INN]
  • Biomol-NT_000108
物化性质
实验特性
LogP 2.02900
PSA 69.64000
折射率 1.7600 (estimate)
沸点 613.9°C at 760 mmHg
颜色与性状 白色结晶。
溶解性 溶于水
密度 1.1527 (rough estimate)
计算特性
精确分子量 385.24800
氢键供体数量 0
氢键受体数量 7
可旋转化学键数量 6
同位素质量 385.24777525g/mol
重原子数量 28
复杂度 529
同位素原子数量 0
确定原子立构中心数量 0
不确定原子立构中心数量 0
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP)
互变异构体数量 3
表面电荷 0
拓扑分子极性表面积 69.6Ų
国际标准相关数据
EINECS 253-072-2
海关数据
海关编码 2933990090
海关数据

中国海关编码:

2933990090

概述:

2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

相关文献
专业数据库参考
PubChemId 2477
化合物详情(旧版)

SMILES

C1=CN=C(N=C1)N2CCN(CCCCN3C(=O)CC4(CCCC4)CC3=O)CC2

960化工网为您提供丁螺环酮专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:36505-84-7,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:36505-84-7
平台客服 平台客服

平台在线客服